Polonca Andermann, Phd

Polonca Andermann, Phd Email and Phone Number

VP Clinical Operations, Head of Clinical Operations, Head Clinical Trials Oncology @ Nouscom AG
Polonca Andermann, Phd's Location
Basel, Basel, Switzerland, Switzerland
Polonca Andermann, Phd's Contact Details

Polonca Andermann, Phd work email

Polonca Andermann, Phd personal email

n/a
About Polonca Andermann, Phd

PhD molecular biologist with 20+ years experience in Clinical Operations/Development in pharmaceutical industry (big pharma and biotech) and CRO.Driven and adaptable manager with demonstrated career progression and experience including line management.Proven record as effective and esteemed team leader of global clinical operations and cross-functional teams.Strong organizational, problem solving skills, effective management of project risks and process change. Excellent communicator accross all levels, good interpersonal skills, able to collaborate and drive the decision making process.Leading by example and striving for excellence to achieve goals.In depth knowledge of ICH/GCP and clinical research regulation in multiple countries across regions.Excellent track record in planning and delivering Phase I-III clinical trials in oncology on target, according to budget and high quality standards.

Polonca Andermann, Phd's Current Company Details
Nouscom AG

Nouscom Ag

View
VP Clinical Operations, Head of Clinical Operations, Head Clinical Trials Oncology
Polonca Andermann, Phd Work Experience Details
  • Nouscom Ag
    Vp Clinical Operations
    Nouscom Ag Jul 2023 - Present
    Bs, Basel-City, Ch
  • Basilea Pharmaceutica
    Head Of Clinical Operations
    Basilea Pharmaceutica Dec 2017 - Jan 2023
    Allschwil, Basel-Country, Ch
  • Teva Pharmaceuticals
    Director, Global Lead Regional Clinical Operations
    Teva Pharmaceuticals May 2016 - Sep 2017
    Tel-Aviv, Il
  • Teva Pharmaceuticals
    Director, Head Of Europe Regional Clinical Operations
    Teva Pharmaceuticals Jun 2014 - Apr 2016
    Tel-Aviv, Il
  • Ganymed Pharmaceuticals Ag
    Head Of Clinical Operations
    Ganymed Pharmaceuticals Ag May 2013 - Jan 2014
    • Expansion and reorganization of Clinical Operations Department to manage an extended clinical development program in oncology• Define and lead departmental process improvements and initiatives• Interact with multiple functions to ensure alignment with clinical development plans and goals• Performance management, training and mentoring of Clinical Trial Managers, CRAs and CTAs (10 direct reports)• Resource, timeline and budget planning• Development of SOPs and tools • Identify, select, and manage CROs and external vendors during execution of clinical trials• Planning and set-up of a multi centric first-in-man Phase I/II in ovarian cancer (5 countries, 30 sites)• Development of a rescue plan and handover to another CRO for a phase II oncology study
  • Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company
    Director, Global Clinical Operations
    Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company Jan 2012 - Feb 2013
    Us
    Leadership and supervision to Clinical Operations staff. Coordination of activities of multiple clinical trials and trial teams across regions. Plan and supervise overall timelines, budget, resources and progress for global and regional clinical trials. Operational leadership for a late phase biopharmaceutical compound development program in cooperation with an alliance partner. Oversight of strategies for geographic set up of studies, selection of sites, patient recruitment and retention. Selection, management and oversight of CROs and external vendors for phase I - III clinical trials in full and functional outsourcing setting. Financial planning and trial budget oversight. Participation in Six Sigma projects for improvement of internal processes.
  • Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company
    Director Clinical Trials
    Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company Apr 2009 - Dec 2011
    Us
    Plan and oversee study timelines, budget, resources and progress of a Development Program. Planning and delivering phase III clinical trials in oncology on target & according to budget. Direct and oversee CRO and vendor activities during all phases of trial conduct, continuously assess key performance and risk indicators. Trial Team Leader for cross-fuctional global teams. Timeline, budget, headcount forecast and management. Management of project risks, change control and CAPA process. Prepare and review key trial documents. Interaction with Regulatory Authorities, managing inspections and audits. Accountable for delivery of two global phase III trials in NCSLC (27 countries, 200 sites, app. 1000 patients each) in fully outsourced setting. Completed enrollment before target date.
  • Icon Clinical Research
    Senior Project Manager
    Icon Clinical Research Apr 2008 - Mar 2009
    Dublin, Ie
    Global Project Manager on a phase III trial in advanced prostate cancer (32 countries, 200 sites, 600 patients). Main liaison for study sponsor. Line manager for 6 regional Project Managers (in-house and remote), 40 indirect reports. Organization and conduct of meetings with clients, third parties and internal team. Global coordination of central laboratory service providers. Supporting business development in preparation and presentation of proposals, bid defense meetings with clients. Set-up and delivery of clinical trials within timelines and budget, resource allocation, budget review, study document development, inspection and audit review. Training of Lead CRAs and Project Managers.
  • Icon Clinical Research
    Clinical Project Manager
    Icon Clinical Research 2004 - Mar 2008
    Dublin, Ie
    Overall cross-functional project responsibility for regional and global clinical trials from start-up till data base lock and close-out involving multi-regional remote teams. Regional Project Manager EU (90 sites, 18 countries) for three global phase III trials in prostate cancer. Project Manager for two phase II trials in NSCLC and colorectal cancer in EU from set-up to data base lock. Leadership of CRA team during study set-up, monitoring and close-out (8 EU countries and South Africa) on a global phase III breast cancer trial. Line manager for 10 direct reports. Mentor and coach for Lead CRAs and CRAs. Business development activities and client business meetings.
  • Icon Clinical Research
    Lead Clinical Research Associate
    Icon Clinical Research Jan 2001 - Dec 2003
    Dublin, Ie
  • Icon Clinical Research
    Clinical Research Associate
    Icon Clinical Research 1999 - 2001
    Dublin, Ie
  • Institut Pasteur, Paris
    Postdoctoral Fellow
    Institut Pasteur, Paris Oct 1995 - Sep 1999
    Paris, Fr
    Human genetics, molecular biologyMolecular biology of Usher syndromeIdentification of cellular proteins interacting with myosin VII using yeast two hybrid system.
  • The Mount Sinai Hospital, New York
    Phd Research / Pre-Doctoral Fellow
    The Mount Sinai Hospital, New York Sep 1991 - Jun 1995
    New York, Ny, Us
    PhD thesis in molecular biology: The role of the cell cycle protein Pendulin in Drosophila melanogaster and its related proteins Srp1 in Saccharomyces cerevisiae during cell proliferation.

Polonca Andermann, Phd Skills

Clinical Trials Cro Clinical Development Oncology Clinical Research Ich Gcp Ctms Clinical Operations Gcp Drug Development Biopharmaceuticals Molecular Biology Clinical Monitoring Pharmaceutical Industry Regulatory Submissions Oncology Clinical Research Edc Pharmacovigilance Cro Oversight Cro Management Pharmacueticals Line Management Clinical Data Management Protocol Biologics Team Leadership Clinical Trial Outsourcing Performance And Risk Monitoring Of Clinical Trials

Polonca Andermann, Phd Education Details

  • University Of Tübingen
    University Of Tübingen
    Molecular Biology / Genetics
  • University Of Tübingen
    University Of Tübingen
    Microbiology
  • University Of Ljubljana
    University Of Ljubljana
    Biology
  • University Of Ljubljana
    University Of Ljubljana

Frequently Asked Questions about Polonca Andermann, Phd

What company does Polonca Andermann, Phd work for?

Polonca Andermann, Phd works for Nouscom Ag

What is Polonca Andermann, Phd's role at the current company?

Polonca Andermann, Phd's current role is VP Clinical Operations, Head of Clinical Operations, Head Clinical Trials Oncology.

What is Polonca Andermann, Phd's email address?

Polonca Andermann, Phd's email address is po****@****lea.com

What schools did Polonca Andermann, Phd attend?

Polonca Andermann, Phd attended University Of Tübingen, University Of Tübingen, University Of Ljubljana, University Of Ljubljana.

What skills is Polonca Andermann, Phd known for?

Polonca Andermann, Phd has skills like Clinical Trials, Cro, Clinical Development, Oncology, Clinical Research, Ich Gcp, Ctms, Clinical Operations, Gcp, Drug Development, Biopharmaceuticals, Molecular Biology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.